Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo Luyuan Pharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of steroid hormone APIs and finished drug products. Founded in 1994 and based in Ningbo, the company has established itself as a significant producer of corticosteroid derivatives, including dexamethasone and betamethasone series. Their facilities are designed to meet international GMP standards, supporting both domestic supply and global exports to markets in Southeast Asia, Europe, and the Americas. The company's portfolio primarily addresses inflammatory conditions, respiratory diseases, and dermatological disorders through high-quality chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo Luyuan Pharmaceutical.